Expression of LGR8 and related biomarkers in hepatocellular carcinoma: Correlation with clinicopathological parameters

Chinese Journal of Physiology

Volumn 54, Issue 3, 2011, Pages 3-

  Lin, Chih kung ^a   Jin, Jong Shiaw ^a   Yu, Cheng Ping ^a   Tsai, Wen Chiuan ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Cortactin; Fascin 1; Immunostaining score; Lgr8; MMP 2; MMP 9; VEGF

Indexed keywords

CORTACTIN; FASCIN; FASCIN 1; G PROTEIN COUPLED RECEPTOR; GELATINASE A; GELATINASE B; LEUCINE RICH REPEAT CONTAINING G PROTEIN COUPLED RECEPTOR 8; TUMOR MARKER; UNCLASSIFIED DRUG; VASCULOTROPIN; ACTIN BINDING PROTEIN; CARRIER PROTEIN; FSCN1 PROTEIN, HUMAN; PARAFFIN; RXFP2 PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; CANCER CELL; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER METASTASIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; SURVIVAL RATE; TISSUE MICROARRAY; TUMOR DIFFERENTIATION; UPREGULATION; BIOSYNTHESIS; CANCER INVASION; FEMALE; LIVER TUMOR; MALE; METABOLISM; METASTASIS; PATHOLOGY;

CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; CORTACTIN; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICROFILAMENT PROTEINS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; PARAFFIN EMBEDDING; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79954465042     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: 10.4077/CJP.2011.AMM021     Document Type: Article

References (36)

1. Adams, J.C. Fascin protrusions in cell interactions. Trends Cardiovasc. Med. 14: 221-226, 2004.
2. Allgaier, H.P., Deibert, P., Olschewski, M., Spamer, C., Blum, U., Gerok, W. and Blum, H.E. Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection- a single-center analysis including 132 patients. Int. J. Cancer 79: 601-605, 1998.
3. Bauknecht, T., Birmelin, A. and Kommoss, F. Clinical significance of oncogenes and growth factors in ovarian carcinomas. J. Steroid Biochem. Mol. Biol. 37: 855-862, 1990.
4. Chuma, M., Sakamoto, M., Yasuda, J., Fujii, G., Nakanishi, K., Tsuchiya, A., Ohta, T., Asaka, M. and Hirohashi, S. Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma. J. Hepatol. 41: 629-636, 2004.
5. Goncharuk, V.N., Ross, J.S. and Carlson, J.A. Actin-binding protein fascin expression in skin neoplasia. J. Cutan. Pathol. 29: 430-438, 2002.
6. Grothey, A., Hashizume, R., Sahin, A.A. and McCrea, P.D. Fascin, an actin-binding protein associated with cell motility, is upregulated in hormone receptor negative breast cancer. Br. J. Cancer 83: 870-873, 2000.
7. Hamilton, S.R. and Aaltonen, L.A. WHO classification of tumors of the digestive system. Lyon: IRAC. 159-180, 2000.
8. Hashimoto, Y., Skacel, M. and Adams, J.C. Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker? Int. J. Biochem. Cell Biol. 37: 1787-1804, 2005.
9. Hisaw, F.L. Experimental relaxation of the pubic ligament of the guinea pig. Proc. Soc. Exp. Biol. Med. 23: 661-663, 1926.
10. Hombach-Klonisch, S., Buchmann, J., Sarun, S., Fischer, B. and Klonisch, T. Relaxin-like factor (RLF) is differentially expressed in the normal and neoplastic human mammary gland. Cancer 89: 2161-2168, 2000.
11. Hombach-Klonisch, S., Hoang-Vu, C., Kehlen, A., Hinze, R., Holzhausen, H.J., Weber, E., Fischer, B., Dralle, H. and Klonisch, T. INSL-3 is expressed in human hyperplastic and neoplastic thyrocytes. Int. J. Oncol. 22: 993-1001, 2003.
12. Hsu, S.Y., Nakabayashi, K., Nishi, S., Kumagai, J., Kudo, M., Sherwood, O.D. and Hsueh, A.J. Activation of orphan receptors by the hormone relaxin. Science 25: 671-674, 2002.
13. Hu, W., McCrea, P.D., Deavers, M., Kavanagh, J.J., Kudelka, A.P. and Verschraegen, C.F. Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumors. Clin. Exp. Metastasis 18: 83-88, 2000.
14. Ivell, R. and Einspanier, A. Relaxin peptides are new global players. Trends Edocrinol. Metab. 13: 343-348, 2002.
15. Jawhari, A.U., Buda, A., Jenkins, M., Shehzad, K., Sarraf, C., Noda, M., Farthing, M.J., Pignatelli, M. and Adams, J.C. Fascin, an actinbundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro. Am. J. Pathol. 162: 69-80, 2003.
16. Klonisch, T., Ivell, R., Balvers, M., Kliesch, S., Fischer, B., Bergmann, M. and Steger, K. Expression of relaxin-like factor is down-regulated in human testicular Leydig cell neoplasia. Mol. Hum. Reprod. 5: 104-108, 1999.
17. Kumagai, J., Hsu, S.Y., Matsumi, H., Roh, J.S., Fu, P., Wade, J.D., Bathgate, R.A. and Hsueh, A.J. INSL3/Leydig insulin-like peptide activates the LGR8 receptor important in testis descent. J. Biol. Chem. 30: 31283-31286, 2002.
18. Mise, M., Arii, S., Higashituji, H., Furutani, M., Niwano, M., Harada, T., Ishigami, S., Toda, Y., Nakayama, H., Fukumoto, M., Fujita, J. and Imamura, M. Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor. Hepatology 23: 455-464, 1996.
19. Musso, O., Théret, N., Campion, J.P., Turlin, B., Milani, S., Grappone, C. and Clément, B. In situ detection of matrix metalloproteinase-2 (MMP2) and the metalloproteinase inhibitor TIMP2 transcripts in human primary hepatocellular carcinoma and in liver metastasis. J. Hepatol. 26: 593-605, 1997.
20. Ormandy, C.J., Musgrove, E.A., Hui, R., Daly, R.J. and Sutherland, R.L. Cyclin D1, EMS1 and 11q13 amplification in breast cancer. Breast Cancer Res. Treat. 78: 323-335, 2003.
21. Parkin, D.M., Pisani, P. and Ferlay, J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int. J. Cancer 80; 827-841, 1990.
22. Parsell, D.A., Mak, J.Y., Amento, E.P. and Unemori, E.N. Relaxin binds to and elicits a response from cells of the human monocytic cell line, THP-1. J. Biol. Chem. 271: 27936-27941, 1996.
23. Pelosi, G., Pastorino, U., Pasini, F., Maissoneuve, P., Fraggetta, F., Iannucci, A., Sonzogni, A., De Manzoni, G., Terzi, A., Durante, E., Bresaola, E., Pezzella, F. and Viale, G. Independent prognostic value of fascin immunoreactivity in Stage I non-small cell lung cancer. Br. J. Cancer 88: 537-547, 2003.
24. Roma, A.A. and Prayson, R.A. Fascin expression in 90 patients with glioblastoma multiforme. Ann. Diagn. Pathol. 9: 307-311, 2005.
25. Schafer, D.F. and Sorrell, M.F. Hepatocellular carcinoma. Lancet 353: 1253-1257, 1999.
26. Schuuring, E. The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes-a review. Gene 159: 83-96, 1995.
27. Silvertown, J.D., Summerlee, A.J. and Klonisch, T. Relaxin-like peptides in cancer. Int. J. Cancer 107: 513-519, 2003.
28. Stemmermann, G.N., Mesiona, W., Greenwood, F.C. and Bryant-Greenwood, G.D. Immunocytochemical identification of a relaxinlike protein in gastrointestinal epithelium and carcinoma: a preliminary report. J. Endocrinol. 140: 321-325, 1994.
29. Sugiura, Y., Shimada, H., Seeger, R.C., Laug, W.E. and DeClerck, Y.A. Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis. Cancer Res. 58: 2209-2216, 1998.
30. Tong, G.X., Yee, H., Chiriboga, L., Hernandes, O. and Waisman, J. Fascin-1 expression in papillary and invasive urothelial carcinomas of the urinary bladder. Hum. Pathol. 36: 741-746, 2005.
31. Tsai, W.C., Jin, J.S., Chang, W.K., Chan, D.C., Yeh, M.K., Cherng, S.C., Lin, L.F., Sheu, L.F. and Chao, Y.C. Association of cortactin and fascin-1 expression in gastric adenocarcinoma: correlation with clinocopathological parameters. Dis. Markers 55: 955-962, 2007.
32. Unemori, E.N., Erikson, M.E., Rocco, S.E., Sutherland, K.M., Parsell, D.A., Mak, J. and Grove, B.H. Relaxin stimulates expression of vascular endothelial growth factor in normal human endometrial cells in vitro and is associated with menometrorrhagia in women. Hum. Reprod. 14: 800-806, 1999.
33. Unemori, E.N., Lewis, M., Constant, J., Arnold, G., Grove, B.H., Normand, J., Deshpande, U., Salles, A., Pickford, L.B., Erikson, M.E., Hunt, T.K. and Huang, X. Relaxin induces vascular endothelial growth factor expression and angiogenesis selectively at wound sites. Wound Repair Regen. 8: 361-370, 2000.
34. Van Rossum, A.G., Moolenaar, W.H. and Schuuring, E. Cortactin affects cell migration by regulating intercellular adhesion and cell spreading. Exp. Cell Res. 312: 1658-1670, 2006.
35. Van Rossum, A.G., Gibcus, J., van der Wal, J. and Schuuring, E. Cortactin overexpression results in sustained epidermal growth factor receptor signaling by preventing ligand-induced receptor degradation in human carcinoma cells. Breast Cancer Res. 7: 235-237, 2005.
36. Weed, S.A. and Parsons, J.T. Cortactin: coupling membrane dynamics to cortical actin assembly. Oncogene 20: 6418-6434, 2001.